Free shipping on all orders over $ 500

Nofazinlimab

Cat. No. M25110

All AbMole products are for research use only, cannot be used for human consumption.

Nofazinlimab Structure
Synonym:

CS1003

Size Price Availability Quantity
100ug USD 180 In stock
1mg USD 400 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Nofazinlimab (CS1003) is a humanised IgG4 anti-PD-1 monoclonal antibody. Nofazinlimab can be used for unresectable hepatocellular carcinoma (uHCC) research. Nofazinlimab is one of a few anti-PD-1 antibodies that can recognize both human and murine PD-1. The binding potency of nofazinlimab to human PD-1 was comparable to that of pembrolizumab (KD: 6.13 nM vs 2.59 nM). Intraperitoneal administration of CS1003 (0.1, 0.5, 2.5 mg/kg, once every 3 days) dose-dependently suppressed the growth of MC38-hPD-L1 colon cancer in hPD-1 knock-in mice.

Chemical Information
CAS Number 2377845-98-0
Storage Store at ≤ -20℃ for 24 months. Avoid repeated freeze-thaw cycles.
References

[1] Fu Li, et al. Acta Pharmacol Sin. CS1003, a novel human and mouse cross-reactive PD-1 monoclonal antibody for cancer therapy

Related PD-1/PD-L1 Products
Avelumab (MSB0010718C)

Avelumab is a whole monoclonal antibody of isotype IgG1 that binds to the programmed death-ligand 1 (PD-L1) and therefore inhibits binding to its receptor programmed cell death 1 (PD-1). Avelumab recognizes murine PD-L1

Panaxadiol

Panaxadiol exists in ginseng root and has neuroprotective and anti-tumor functions. Panaxadiol inhibits the expression of programmed cell death ligand-1 (PD-L1) and tumor proliferation.

Fraxinellone

Fraxinellone was isolated from the root bark of the brassica family Dictamnus dasycarpus. Fraxinellone is a PD-L1 inhibitor that inhibits HIF-1α synthesis without affecting HIF-1α degradation. Fraxinellone has potential for cancer immunity by targeting PD-L1.

BMS202

Bms-202 is an effective non-peptide PD-1/PD-L complex inhibitor with IC50 of 18 nM and KD of 8 μM. Bms-202 directly binds to PD-L1 and blocks the human PD-1/PD-L interaction. Bms-202 has antitumor activity.

Sulfamethoxypyridazine

Sulfamethoxypyridazine is a long-acting sulfonamide for treatment of Dermatitis herpetiformis.

  Catalog
Abmole Inhibitor Catalog




Keywords: Nofazinlimab, CS1003 supplier, PD-1/PD-L1, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.